Floatz logo

Daunorubicin

Ph-Like Acute Lymphoblastic Leukemia

City of Hope Medical CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Ph-Like Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2B
MERCAPTOPURINE ANHYDROUS
City of Hope Medical Center
Phase 2B
Cytosin-Arabinosid
City of Hope Medical Center
Phase 2B
METHOTREXATE
City of Hope Medical Center
Phase 2B
Cyclophosphamide
City of Hope Medical Center
Phase 2B

View all 16 →

Same molecule, other indications

Daunorubicin is also rated in:

acute myeloid leukemia by FAB classificationDormant
BBB
Indicative ·
78 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
77 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →